nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Pimecrolimus—atopic dermatitis	0.099	0.178	CbGbCtD
Bexarotene—CYP2C9—Loratadine—atopic dermatitis	0.0741	0.133	CbGbCtD
Bexarotene—CYP2C9—Diphenhydramine—atopic dermatitis	0.0741	0.133	CbGbCtD
Bexarotene—CYP3A4—Tacrolimus—atopic dermatitis	0.0589	0.106	CbGbCtD
Bexarotene—CYP3A4—Loratadine—atopic dermatitis	0.0431	0.0773	CbGbCtD
Bexarotene—CYP3A4—Methylprednisolone—atopic dermatitis	0.0394	0.0707	CbGbCtD
Bexarotene—CYP3A4—Triamcinolone—atopic dermatitis	0.0299	0.0536	CbGbCtD
Bexarotene—CYP2C9—Dexamethasone—atopic dermatitis	0.0256	0.046	CbGbCtD
Bexarotene—CYP3A4—Betamethasone—atopic dermatitis	0.0256	0.0459	CbGbCtD
Bexarotene—CYP3A4—Prednisolone—atopic dermatitis	0.0253	0.0453	CbGbCtD
Bexarotene—CYP3A4—Hydrocortisone—atopic dermatitis	0.024	0.043	CbGbCtD
Bexarotene—CYP3A4—Prednisone—atopic dermatitis	0.0239	0.0428	CbGbCtD
Bexarotene—CYP3A4—Dexamethasone—atopic dermatitis	0.0149	0.0267	CbGbCtD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000269	0.0564	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000253	0.053	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—PPARA—atopic dermatitis	0.000198	0.0416	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—PPARA—atopic dermatitis	0.000186	0.0391	CbGpPWpGaD
Bexarotene—Discomfort—Prednisolone—atopic dermatitis	0.000177	0.000404	CcSEcCtD
Bexarotene—Haemoglobin—Prednisone—atopic dermatitis	0.000176	0.000403	CcSEcCtD
Bexarotene—Haemorrhage—Prednisone—atopic dermatitis	0.000176	0.000401	CcSEcCtD
Bexarotene—Erythema—Betamethasone—atopic dermatitis	0.000175	0.000401	CcSEcCtD
Bexarotene—Erythema—Dexamethasone—atopic dermatitis	0.000175	0.000401	CcSEcCtD
Bexarotene—Myalgia—Hydrocortisone—atopic dermatitis	0.000175	0.0004	CcSEcCtD
Bexarotene—Malaise—Triamcinolone—atopic dermatitis	0.000174	0.000399	CcSEcCtD
Bexarotene—Anxiety—Hydrocortisone—atopic dermatitis	0.000174	0.000398	CcSEcCtD
Bexarotene—Malaise—Methylprednisolone—atopic dermatitis	0.000174	0.000398	CcSEcCtD
Bexarotene—Vertigo—Triamcinolone—atopic dermatitis	0.000174	0.000397	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000174	0.000397	CcSEcCtD
Bexarotene—Syncope—Triamcinolone—atopic dermatitis	0.000173	0.000397	CcSEcCtD
Bexarotene—Vertigo—Methylprednisolone—atopic dermatitis	0.000173	0.000396	CcSEcCtD
Bexarotene—Syncope—Methylprednisolone—atopic dermatitis	0.000173	0.000396	CcSEcCtD
Bexarotene—Discomfort—Hydrocortisone—atopic dermatitis	0.000173	0.000395	CcSEcCtD
Bexarotene—Connective tissue disorder—Prednisone—atopic dermatitis	0.000172	0.000394	CcSEcCtD
Bexarotene—Oedema—Prednisolone—atopic dermatitis	0.000172	0.000392	CcSEcCtD
Bexarotene—Vomiting—Tacrolimus—atopic dermatitis	0.000171	0.000391	CcSEcCtD
Bexarotene—Loss of consciousness—Triamcinolone—atopic dermatitis	0.00017	0.000389	CcSEcCtD
Bexarotene—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.00017	0.000388	CcSEcCtD
Bexarotene—Rash—Tacrolimus—atopic dermatitis	0.000169	0.000387	CcSEcCtD
Bexarotene—Dermatitis—Tacrolimus—atopic dermatitis	0.000169	0.000387	CcSEcCtD
Bexarotene—Shock—Prednisolone—atopic dermatitis	0.000169	0.000386	CcSEcCtD
Bexarotene—Cough—Triamcinolone—atopic dermatitis	0.000169	0.000386	CcSEcCtD
Bexarotene—Headache—Tacrolimus—atopic dermatitis	0.000168	0.000385	CcSEcCtD
Bexarotene—Oedema—Hydrocortisone—atopic dermatitis	0.000168	0.000383	CcSEcCtD
Bexarotene—Tachycardia—Prednisolone—atopic dermatitis	0.000167	0.000383	CcSEcCtD
Bexarotene—Hypertension—Triamcinolone—atopic dermatitis	0.000167	0.000382	CcSEcCtD
Bexarotene—Hypertension—Methylprednisolone—atopic dermatitis	0.000167	0.000381	CcSEcCtD
Bexarotene—Infection—Hydrocortisone—atopic dermatitis	0.000167	0.000381	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000166	0.000379	CcSEcCtD
Bexarotene—Shock—Hydrocortisone—atopic dermatitis	0.000165	0.000377	CcSEcCtD
Bexarotene—Myalgia—Triamcinolone—atopic dermatitis	0.000165	0.000376	CcSEcCtD
Bexarotene—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000164	0.000376	CcSEcCtD
Bexarotene—Myalgia—Methylprednisolone—atopic dermatitis	0.000164	0.000376	CcSEcCtD
Bexarotene—Arthralgia—Methylprednisolone—atopic dermatitis	0.000164	0.000376	CcSEcCtD
Bexarotene—Eye disorder—Prednisone—atopic dermatitis	0.000164	0.000375	CcSEcCtD
Bexarotene—Anxiety—Methylprednisolone—atopic dermatitis	0.000164	0.000374	CcSEcCtD
Bexarotene—Tachycardia—Hydrocortisone—atopic dermatitis	0.000164	0.000374	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000163	0.000373	CcSEcCtD
Bexarotene—Skin disorder—Hydrocortisone—atopic dermatitis	0.000163	0.000372	CcSEcCtD
Bexarotene—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000163	0.000372	CcSEcCtD
Bexarotene—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000163	0.000372	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—STAT6—atopic dermatitis	0.000163	0.0341	CbGpPWpGaD
Bexarotene—Discomfort—Triamcinolone—atopic dermatitis	0.000163	0.000372	CcSEcCtD
Bexarotene—Discomfort—Methylprednisolone—atopic dermatitis	0.000162	0.000371	CcSEcCtD
Bexarotene—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000162	0.00037	CcSEcCtD
Bexarotene—Dry mouth—Triamcinolone—atopic dermatitis	0.000161	0.000368	CcSEcCtD
Bexarotene—Anorexia—Hydrocortisone—atopic dermatitis	0.00016	0.000365	CcSEcCtD
Bexarotene—Nausea—Tacrolimus—atopic dermatitis	0.00016	0.000365	CcSEcCtD
Bexarotene—Angiopathy—Prednisone—atopic dermatitis	0.000159	0.000364	CcSEcCtD
Bexarotene—Confusional state—Methylprednisolone—atopic dermatitis	0.000159	0.000363	CcSEcCtD
Bexarotene—Malaise—Betamethasone—atopic dermatitis	0.000158	0.000362	CcSEcCtD
Bexarotene—Malaise—Dexamethasone—atopic dermatitis	0.000158	0.000362	CcSEcCtD
Bexarotene—Oedema—Triamcinolone—atopic dermatitis	0.000158	0.000361	CcSEcCtD
Bexarotene—Vertigo—Betamethasone—atopic dermatitis	0.000158	0.00036	CcSEcCtD
Bexarotene—Vertigo—Dexamethasone—atopic dermatitis	0.000158	0.00036	CcSEcCtD
Bexarotene—Syncope—Betamethasone—atopic dermatitis	0.000157	0.00036	CcSEcCtD
Bexarotene—Syncope—Dexamethasone—atopic dermatitis	0.000157	0.00036	CcSEcCtD
Bexarotene—Arrhythmia—Prednisone—atopic dermatitis	0.000157	0.000359	CcSEcCtD
Bexarotene—Infection—Triamcinolone—atopic dermatitis	0.000157	0.000359	CcSEcCtD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000157	0.0329	CbGpPWpGaD
Bexarotene—Infection—Methylprednisolone—atopic dermatitis	0.000156	0.000358	CcSEcCtD
Bexarotene—Shock—Triamcinolone—atopic dermatitis	0.000155	0.000355	CcSEcCtD
Bexarotene—Insomnia—Prednisolone—atopic dermatitis	0.000155	0.000355	CcSEcCtD
Bexarotene—Alopecia—Prednisone—atopic dermatitis	0.000155	0.000355	CcSEcCtD
Bexarotene—Shock—Methylprednisolone—atopic dermatitis	0.000155	0.000354	CcSEcCtD
Bexarotene—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000154	0.000353	CcSEcCtD
Bexarotene—Loss of consciousness—Betamethasone—atopic dermatitis	0.000154	0.000353	CcSEcCtD
Bexarotene—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000154	0.000353	CcSEcCtD
Bexarotene—Paraesthesia—Prednisolone—atopic dermatitis	0.000154	0.000352	CcSEcCtD
Bexarotene—Tachycardia—Triamcinolone—atopic dermatitis	0.000154	0.000352	CcSEcCtD
Bexarotene—Tachycardia—Methylprednisolone—atopic dermatitis	0.000154	0.000351	CcSEcCtD
Bexarotene—Skin disorder—Methylprednisolone—atopic dermatitis	0.000153	0.00035	CcSEcCtD
Bexarotene—Malnutrition—Prednisone—atopic dermatitis	0.000153	0.000349	CcSEcCtD
Bexarotene—Erythema—Prednisone—atopic dermatitis	0.000153	0.000349	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000153	0.000349	CcSEcCtD
Bexarotene—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000153	0.000349	CcSEcCtD
Bexarotene—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000152	0.000348	CcSEcCtD
Bexarotene—Insomnia—Hydrocortisone—atopic dermatitis	0.000152	0.000347	CcSEcCtD
Bexarotene—Hypertension—Betamethasone—atopic dermatitis	0.000151	0.000346	CcSEcCtD
Bexarotene—Hypertension—Dexamethasone—atopic dermatitis	0.000151	0.000346	CcSEcCtD
Bexarotene—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000151	0.000344	CcSEcCtD
Bexarotene—Myalgia—Dexamethasone—atopic dermatitis	0.000149	0.000342	CcSEcCtD
Bexarotene—Myalgia—Betamethasone—atopic dermatitis	0.000149	0.000342	CcSEcCtD
Bexarotene—Anxiety—Betamethasone—atopic dermatitis	0.000149	0.00034	CcSEcCtD
Bexarotene—Anxiety—Dexamethasone—atopic dermatitis	0.000149	0.00034	CcSEcCtD
Bexarotene—Discomfort—Dexamethasone—atopic dermatitis	0.000148	0.000337	CcSEcCtD
Bexarotene—Discomfort—Betamethasone—atopic dermatitis	0.000148	0.000337	CcSEcCtD
Bexarotene—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000148	0.000337	CcSEcCtD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000147	0.0309	CbGpPWpGaD
Bexarotene—Pain—Prednisolone—atopic dermatitis	0.000147	0.000336	CcSEcCtD
Bexarotene—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000146	0.000333	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000145	0.000331	CcSEcCtD
Bexarotene—Fatigue—Hydrocortisone—atopic dermatitis	0.000145	0.00033	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000144	0.000329	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000143	0.000328	CcSEcCtD
Bexarotene—Pain—Hydrocortisone—atopic dermatitis	0.000143	0.000328	CcSEcCtD
Bexarotene—Oedema—Betamethasone—atopic dermatitis	0.000143	0.000327	CcSEcCtD
Bexarotene—Oedema—Dexamethasone—atopic dermatitis	0.000143	0.000327	CcSEcCtD
Bexarotene—Insomnia—Triamcinolone—atopic dermatitis	0.000143	0.000326	CcSEcCtD
Bexarotene—Insomnia—Methylprednisolone—atopic dermatitis	0.000142	0.000326	CcSEcCtD
Bexarotene—Infection—Dexamethasone—atopic dermatitis	0.000142	0.000325	CcSEcCtD
Bexarotene—Infection—Betamethasone—atopic dermatitis	0.000142	0.000325	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—atopic dermatitis	0.000142	0.000324	CcSEcCtD
Bexarotene—Paraesthesia—Triamcinolone—atopic dermatitis	0.000142	0.000324	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisolone—atopic dermatitis	0.000141	0.000323	CcSEcCtD
Bexarotene—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000141	0.000323	CcSEcCtD
Bexarotene—Anaemia—Prednisone—atopic dermatitis	0.000141	0.000323	CcSEcCtD
Bexarotene—Shock—Betamethasone—atopic dermatitis	0.000141	0.000322	CcSEcCtD
Bexarotene—Shock—Dexamethasone—atopic dermatitis	0.000141	0.000322	CcSEcCtD
Bexarotene—Dyspnoea—Triamcinolone—atopic dermatitis	0.000141	0.000322	CcSEcCtD
Bexarotene—Nervous system disorder—Betamethasone—atopic dermatitis	0.00014	0.000321	CcSEcCtD
Bexarotene—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00014	0.000321	CcSEcCtD
Bexarotene—Agitation—Prednisone—atopic dermatitis	0.00014	0.000321	CcSEcCtD
Bexarotene—RXRA—REV-ERBA represses gene expression—PPARA—atopic dermatitis	0.00014	0.0294	CbGpPWpGaD
Bexarotene—Thrombocytopenia—Betamethasone—atopic dermatitis	0.00014	0.000321	CcSEcCtD
Bexarotene—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.00014	0.000321	CcSEcCtD
Bexarotene—Tachycardia—Betamethasone—atopic dermatitis	0.00014	0.00032	CcSEcCtD
Bexarotene—Tachycardia—Dexamethasone—atopic dermatitis	0.00014	0.00032	CcSEcCtD
Bexarotene—Dyspepsia—Triamcinolone—atopic dermatitis	0.000139	0.000318	CcSEcCtD
Bexarotene—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000139	0.000317	CcSEcCtD
Bexarotene—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000138	0.000317	CcSEcCtD
Bexarotene—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000138	0.000317	CcSEcCtD
Bexarotene—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000138	0.000316	CcSEcCtD
Bexarotene—Malaise—Prednisone—atopic dermatitis	0.000138	0.000315	CcSEcCtD
Bexarotene—Vertigo—Prednisone—atopic dermatitis	0.000137	0.000314	CcSEcCtD
Bexarotene—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000137	0.000313	CcSEcCtD
Bexarotene—Syncope—Prednisone—atopic dermatitis	0.000137	0.000313	CcSEcCtD
Bexarotene—Anorexia—Dexamethasone—atopic dermatitis	0.000136	0.000312	CcSEcCtD
Bexarotene—Anorexia—Betamethasone—atopic dermatitis	0.000136	0.000312	CcSEcCtD
Bexarotene—Fatigue—Triamcinolone—atopic dermatitis	0.000136	0.000311	CcSEcCtD
Bexarotene—RXRA—RORA activates circadian gene expression—PPARA—atopic dermatitis	0.000136	0.0285	CbGpPWpGaD
Bexarotene—Fatigue—Methylprednisolone—atopic dermatitis	0.000136	0.00031	CcSEcCtD
Bexarotene—Pain—Triamcinolone—atopic dermatitis	0.000135	0.000309	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—atopic dermatitis	0.000134	0.000307	CcSEcCtD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000133	0.0279	CbGpPWpGaD
Bexarotene—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000132	0.000303	CcSEcCtD
Bexarotene—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000132	0.000303	CcSEcCtD
Bexarotene—Hypertension—Prednisone—atopic dermatitis	0.000132	0.000302	CcSEcCtD
Bexarotene—RXRA—PPAR Alpha Pathway—PPARA—atopic dermatitis	0.000132	0.0276	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.000132	0.0276	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.00013	0.000298	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.00013	0.000298	CcSEcCtD
Bexarotene—Myalgia—Prednisone—atopic dermatitis	0.00013	0.000297	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—atopic dermatitis	0.00013	0.000297	CcSEcCtD
Bexarotene—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00013	0.000297	CcSEcCtD
Bexarotene—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.00013	0.000297	CcSEcCtD
Bexarotene—Anxiety—Prednisone—atopic dermatitis	0.00013	0.000296	CcSEcCtD
Bexarotene—Insomnia—Dexamethasone—atopic dermatitis	0.00013	0.000296	CcSEcCtD
Bexarotene—Insomnia—Betamethasone—atopic dermatitis	0.00013	0.000296	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000129	0.000295	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000129	0.000294	CcSEcCtD
Bexarotene—Paraesthesia—Betamethasone—atopic dermatitis	0.000129	0.000294	CcSEcCtD
Bexarotene—Paraesthesia—Dexamethasone—atopic dermatitis	0.000129	0.000294	CcSEcCtD
Bexarotene—Discomfort—Prednisone—atopic dermatitis	0.000129	0.000294	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisolone—atopic dermatitis	0.000126	0.000289	CcSEcCtD
Bexarotene—Dyspepsia—Betamethasone—atopic dermatitis	0.000126	0.000288	CcSEcCtD
Bexarotene—Dyspepsia—Dexamethasone—atopic dermatitis	0.000126	0.000288	CcSEcCtD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	0.000125	0.0262	CbGpPWpGaD
Bexarotene—Body temperature increased—Triamcinolone—atopic dermatitis	0.000125	0.000285	CcSEcCtD
Bexarotene—Oedema—Prednisone—atopic dermatitis	0.000125	0.000285	CcSEcCtD
Bexarotene—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000124	0.000285	CcSEcCtD
Bexarotene—Decreased appetite—Betamethasone—atopic dermatitis	0.000124	0.000285	CcSEcCtD
Bexarotene—Decreased appetite—Dexamethasone—atopic dermatitis	0.000124	0.000285	CcSEcCtD
Bexarotene—Infection—Prednisone—atopic dermatitis	0.000124	0.000283	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000124	0.000283	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000124	0.000283	CcSEcCtD
Bexarotene—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000123	0.000282	CcSEcCtD
Bexarotene—Fatigue—Dexamethasone—atopic dermatitis	0.000123	0.000282	CcSEcCtD
Bexarotene—Fatigue—Betamethasone—atopic dermatitis	0.000123	0.000282	CcSEcCtD
Bexarotene—Shock—Prednisone—atopic dermatitis	0.000123	0.000281	CcSEcCtD
Bexarotene—Pain—Betamethasone—atopic dermatitis	0.000122	0.00028	CcSEcCtD
Bexarotene—Pain—Dexamethasone—atopic dermatitis	0.000122	0.00028	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—atopic dermatitis	0.000122	0.00028	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—atopic dermatitis	0.000122	0.000278	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—atopic dermatitis	0.000121	0.000277	CcSEcCtD
Bexarotene—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—PPARA—atopic dermatitis	0.000121	0.0253	CbGpPWpGaD
Bexarotene—Hyperhidrosis—Prednisone—atopic dermatitis	0.000121	0.000276	CcSEcCtD
Bexarotene—Asthenia—Hydrocortisone—atopic dermatitis	0.00012	0.000275	CcSEcCtD
Bexarotene—Anorexia—Prednisone—atopic dermatitis	0.000119	0.000272	CcSEcCtD
Bexarotene—Pruritus—Hydrocortisone—atopic dermatitis	0.000119	0.000271	CcSEcCtD
Bexarotene—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000118	0.00027	CcSEcCtD
Bexarotene—Feeling abnormal—Betamethasone—atopic dermatitis	0.000118	0.00027	CcSEcCtD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000118	0.0247	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000117	0.000268	CcSEcCtD
Bexarotene—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000117	0.000268	CcSEcCtD
Bexarotene—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000116	0.000266	CcSEcCtD
Bexarotene—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000116	0.000265	CcSEcCtD
Bexarotene—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000115	0.000262	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000114	0.00026	CcSEcCtD
Bexarotene—Dizziness—Prednisolone—atopic dermatitis	0.000113	0.000259	CcSEcCtD
Bexarotene—Asthenia—Triamcinolone—atopic dermatitis	0.000113	0.000259	CcSEcCtD
Bexarotene—Abdominal pain—Betamethasone—atopic dermatitis	0.000113	0.000259	CcSEcCtD
Bexarotene—Body temperature increased—Betamethasone—atopic dermatitis	0.000113	0.000259	CcSEcCtD
Bexarotene—Abdominal pain—Dexamethasone—atopic dermatitis	0.000113	0.000259	CcSEcCtD
Bexarotene—Body temperature increased—Dexamethasone—atopic dermatitis	0.000113	0.000259	CcSEcCtD
Bexarotene—Asthenia—Methylprednisolone—atopic dermatitis	0.000113	0.000258	CcSEcCtD
Bexarotene—Insomnia—Prednisone—atopic dermatitis	0.000113	0.000258	CcSEcCtD
Bexarotene—Paraesthesia—Prednisone—atopic dermatitis	0.000112	0.000256	CcSEcCtD
Bexarotene—Pruritus—Triamcinolone—atopic dermatitis	0.000112	0.000255	CcSEcCtD
Bexarotene—Pruritus—Methylprednisolone—atopic dermatitis	0.000111	0.000255	CcSEcCtD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000111	0.0233	CbGpPWpGaD
Bexarotene—Dizziness—Hydrocortisone—atopic dermatitis	0.000111	0.000253	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—atopic dermatitis	0.00011	0.000251	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—atopic dermatitis	0.000108	0.000248	CcSEcCtD
Bexarotene—Rash—Prednisolone—atopic dermatitis	0.000108	0.000247	CcSEcCtD
Bexarotene—Dermatitis—Prednisolone—atopic dermatitis	0.000108	0.000247	CcSEcCtD
Bexarotene—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000108	0.000246	CcSEcCtD
Bexarotene—Fatigue—Prednisone—atopic dermatitis	0.000108	0.000246	CcSEcCtD
Bexarotene—Headache—Prednisolone—atopic dermatitis	0.000108	0.000246	CcSEcCtD
Bexarotene—Constipation—Prednisone—atopic dermatitis	0.000107	0.000244	CcSEcCtD
Bexarotene—Vomiting—Hydrocortisone—atopic dermatitis	0.000107	0.000244	CcSEcCtD
Bexarotene—Rash—Hydrocortisone—atopic dermatitis	0.000106	0.000242	CcSEcCtD
Bexarotene—Dermatitis—Hydrocortisone—atopic dermatitis	0.000106	0.000241	CcSEcCtD
Bexarotene—Headache—Hydrocortisone—atopic dermatitis	0.000105	0.00024	CcSEcCtD
Bexarotene—Dizziness—Triamcinolone—atopic dermatitis	0.000104	0.000239	CcSEcCtD
Bexarotene—Dizziness—Methylprednisolone—atopic dermatitis	0.000104	0.000238	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—atopic dermatitis	0.000103	0.000235	CcSEcCtD
Bexarotene—Asthenia—Dexamethasone—atopic dermatitis	0.000103	0.000235	CcSEcCtD
Bexarotene—Asthenia—Betamethasone—atopic dermatitis	0.000103	0.000235	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000102	0.000233	CcSEcCtD
Bexarotene—Nausea—Prednisolone—atopic dermatitis	0.000102	0.000233	CcSEcCtD
Bexarotene—Pruritus—Dexamethasone—atopic dermatitis	0.000101	0.000232	CcSEcCtD
Bexarotene—Pruritus—Betamethasone—atopic dermatitis	0.000101	0.000232	CcSEcCtD
Bexarotene—Vomiting—Triamcinolone—atopic dermatitis	0.0001	0.000229	CcSEcCtD
Bexarotene—Vomiting—Methylprednisolone—atopic dermatitis	0.0001	0.000229	CcSEcCtD
Bexarotene—Nausea—Hydrocortisone—atopic dermatitis	9.96e-05	0.000228	CcSEcCtD
Bexarotene—Rash—Triamcinolone—atopic dermatitis	9.95e-05	0.000228	CcSEcCtD
Bexarotene—Dermatitis—Triamcinolone—atopic dermatitis	9.94e-05	0.000227	CcSEcCtD
Bexarotene—Rash—Methylprednisolone—atopic dermatitis	9.93e-05	0.000227	CcSEcCtD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atopic dermatitis	9.92e-05	0.0208	CbGpPWpGaD
Bexarotene—Dermatitis—Methylprednisolone—atopic dermatitis	9.92e-05	0.000227	CcSEcCtD
Bexarotene—Headache—Triamcinolone—atopic dermatitis	9.89e-05	0.000226	CcSEcCtD
Bexarotene—Headache—Methylprednisolone—atopic dermatitis	9.86e-05	0.000226	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—atopic dermatitis	9.86e-05	0.000225	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—atopic dermatitis	9.86e-05	0.000225	CcSEcCtD
Bexarotene—Diarrhoea—Dexamethasone—atopic dermatitis	9.8e-05	0.000224	CcSEcCtD
Bexarotene—Diarrhoea—Betamethasone—atopic dermatitis	9.8e-05	0.000224	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptors—PPARA—atopic dermatitis	9.71e-05	0.0204	CbGpPWpGaD
Bexarotene—Dizziness—Dexamethasone—atopic dermatitis	9.47e-05	0.000217	CcSEcCtD
Bexarotene—Dizziness—Betamethasone—atopic dermatitis	9.47e-05	0.000217	CcSEcCtD
Bexarotene—Nausea—Triamcinolone—atopic dermatitis	9.37e-05	0.000214	CcSEcCtD
Bexarotene—Nausea—Methylprednisolone—atopic dermatitis	9.35e-05	0.000214	CcSEcCtD
Bexarotene—RXRA—Activation of gene expression by SREBF (SREBP)—PPARA—atopic dermatitis	9.32e-05	0.0196	CbGpPWpGaD
Bexarotene—Hypersensitivity—Prednisone—atopic dermatitis	9.19e-05	0.00021	CcSEcCtD
Bexarotene—Vomiting—Dexamethasone—atopic dermatitis	9.1e-05	0.000208	CcSEcCtD
Bexarotene—Vomiting—Betamethasone—atopic dermatitis	9.1e-05	0.000208	CcSEcCtD
Bexarotene—Rash—Dexamethasone—atopic dermatitis	9.03e-05	0.000206	CcSEcCtD
Bexarotene—Rash—Betamethasone—atopic dermatitis	9.03e-05	0.000206	CcSEcCtD
Bexarotene—Dermatitis—Betamethasone—atopic dermatitis	9.02e-05	0.000206	CcSEcCtD
Bexarotene—Dermatitis—Dexamethasone—atopic dermatitis	9.02e-05	0.000206	CcSEcCtD
Bexarotene—Headache—Dexamethasone—atopic dermatitis	8.97e-05	0.000205	CcSEcCtD
Bexarotene—Headache—Betamethasone—atopic dermatitis	8.97e-05	0.000205	CcSEcCtD
Bexarotene—Asthenia—Prednisone—atopic dermatitis	8.95e-05	0.000205	CcSEcCtD
Bexarotene—Pruritus—Prednisone—atopic dermatitis	8.82e-05	0.000202	CcSEcCtD
Bexarotene—Diarrhoea—Prednisone—atopic dermatitis	8.53e-05	0.000195	CcSEcCtD
Bexarotene—Nausea—Betamethasone—atopic dermatitis	8.51e-05	0.000194	CcSEcCtD
Bexarotene—Nausea—Dexamethasone—atopic dermatitis	8.51e-05	0.000194	CcSEcCtD
Bexarotene—RXRA—Transcriptional activation of mitochondrial biogenesis—PPARA—atopic dermatitis	8.49e-05	0.0178	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	8.43e-05	0.0177	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—MAPK8—atopic dermatitis	8.34e-05	0.0175	CbGpPWpGaD
Bexarotene—Dizziness—Prednisone—atopic dermatitis	8.25e-05	0.000189	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—STAT6—atopic dermatitis	7.97e-05	0.0167	CbGpPWpGaD
Bexarotene—Vomiting—Prednisone—atopic dermatitis	7.93e-05	0.000181	CcSEcCtD
Bexarotene—RXRB—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	7.92e-05	0.0166	CbGpPWpGaD
Bexarotene—Rash—Prednisone—atopic dermatitis	7.86e-05	0.00018	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—atopic dermatitis	7.86e-05	0.00018	CcSEcCtD
Bexarotene—Headache—Prednisone—atopic dermatitis	7.81e-05	0.000179	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	7.68e-05	0.0161	CbGpPWpGaD
Bexarotene—RXRA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—atopic dermatitis	7.44e-05	0.0156	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—PPARA—atopic dermatitis	7.41e-05	0.0156	CbGpPWpGaD
Bexarotene—Nausea—Prednisone—atopic dermatitis	7.41e-05	0.000169	CcSEcCtD
Bexarotene—RXRA—Mitochondrial biogenesis—PPARA—atopic dermatitis	7.33e-05	0.0154	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—PPARA—atopic dermatitis	7.23e-05	0.0152	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—TNF—atopic dermatitis	6.6e-05	0.0139	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—MAPK8—atopic dermatitis	6.51e-05	0.0137	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	5.96e-05	0.0125	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	5.78e-05	0.0121	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARA—atopic dermatitis	5.52e-05	0.0116	CbGpPWpGaD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—IL6—atopic dermatitis	5.33e-05	0.0112	CbGpPWpGaD
Bexarotene—RXRA—Orphan transporters—PPARA—atopic dermatitis	4.34e-05	0.00911	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—PPARA—atopic dermatitis	4.15e-05	0.00871	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—MAPK8—atopic dermatitis	4.13e-05	0.00867	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	4.06e-05	0.00852	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	3.96e-05	0.00832	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—PPARA—atopic dermatitis	3.63e-05	0.00762	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.43e-05	0.00721	CbGpPWpGaD
Bexarotene—RXRA—Organelle biogenesis and maintenance—PPARA—atopic dermatitis	3.33e-05	0.00698	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TNF—atopic dermatitis	3.25e-05	0.00683	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.22e-05	0.00677	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	2.8e-05	0.00587	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PPARA—atopic dermatitis	2.71e-05	0.00568	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—IL6—atopic dermatitis	2.63e-05	0.00551	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.61e-05	0.00549	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARA—atopic dermatitis	2.54e-05	0.00534	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—atopic dermatitis	2.42e-05	0.00509	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.36e-05	0.00495	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.19e-05	0.00459	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.13e-05	0.00447	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TNF—atopic dermatitis	1.59e-05	0.00335	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GLB1—atopic dermatitis	1.53e-05	0.00321	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.48e-05	0.00311	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADSL—atopic dermatitis	1.47e-05	0.00308	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARA—atopic dermatitis	1.33e-05	0.00278	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARA—atopic dermatitis	1.3e-05	0.00273	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IL6—atopic dermatitis	1.29e-05	0.0027	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.28e-05	0.00269	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARA—atopic dermatitis	1.25e-05	0.00262	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARA—atopic dermatitis	1.22e-05	0.00257	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.17e-05	0.00246	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.11e-05	0.00234	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.06e-05	0.00222	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARA—atopic dermatitis	6.38e-06	0.00134	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GLB1—atopic dermatitis	5.71e-06	0.0012	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TNF—atopic dermatitis	5.48e-06	0.00115	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADSL—atopic dermatitis	5.47e-06	0.00115	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARA—atopic dermatitis	4.96e-06	0.00104	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—IL6—atopic dermatitis	4.42e-06	0.000928	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.16e-06	0.000873	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.77e-06	0.00079	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.61e-06	0.000758	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.85e-06	0.000389	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.22e-06	0.000256	CbGpPWpGaD
